HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human T cell recognition of cloned HLA class I gene products expressed on DNA transfectants of mouse mastocytoma P815.

Abstract
Cloned genes for human major histocompatibility complex (MHC) class I antigens were introduced by DNA-mediated gene transfer into a high-efficiency transfection recipient (HTR) cell line previously derived from mouse mastocytoma P815. Cell surface expression of HLA-A3, AW24 and CW3 gene products on P815 transfectants was demonstrated by radioimmune assay and by flow cytometry. The human MHC class I gene products were apparently expressed on P815 transfectants in a form recognized by human cytolytic T lymphocytes (CTL). Human CTL generated in unidirectional mixed lymphocyte culture against AW24+ donor lymphocytes clearly lysed P815-HLA-AW24+ transfectant target cells, but not untransfected P815(HTR) controls. Moreover, P815-HLA transfectants could stimulate in vitro a significant alloreactive human CTL response. Lysis of P815-HLA transfectant target cells by human CTL was inhibited by a monoclonal antibody directed against human MHC class I gene products. These mouse cell transfectants may be useful for the study of human T cell responses.
AuthorsJ L Maryanski, A Moretta, B Jordan, E De Plaen, A Van Pel, T Boon, J C Cerottini
JournalEuropean journal of immunology (Eur J Immunol) Vol. 15 Issue 11 Pg. 1111-7 (Nov 1985) ISSN: 0014-2980 [Print] Germany
PMID2933264 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • HLA Antigens
  • DNA
Topics
  • Animals
  • Antibodies, Monoclonal (physiology)
  • Binding, Competitive
  • Cloning, Molecular
  • Cytotoxicity, Immunologic
  • DNA (metabolism)
  • Genes, MHC Class II
  • HLA Antigens (genetics, immunology)
  • Lymphocyte Activation
  • Lymphocyte Culture Test, Mixed
  • Mast-Cell Sarcoma (genetics, immunology)
  • Mice
  • T-Lymphocytes, Cytotoxic (immunology, metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: